CRISPR-engineered T cells in patients with refractory cancer | Science
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research: Molecular Therapy - Methods & Clinical Development
Nature Medicine on Twitter: "Two studies find that #AAV-mediated #CRISPR/ Cas9 therapy extends life span and ameliorates disease-related phenotypes in a mouse model of #progeria. https://t.co/2LfOogSXLX and https://t.co/y5KjuD5Yjb… https://t.co/RMaa25wQoI"
CRISPR, the disruptor : Nature News & Comment
:no_upscale()/cdn.vox-cdn.com/uploads/chorus_image/image/60457727/CRISPR_LEAD.0.jpg "CRISPR, one of the biggest science stories of the decade, explained - Vox")
CRISPR, one of the biggest science stories of the decade, explained - Vox
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review
Is Crispr the Next Antibiotic? - The New York Times
Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome | Request PDF
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects | Signal Transduction and Targeted Therapy
CRISPR algorithm predicts how well gene editing will work - Scope
CRISPR-Cas 9 corrects genetic defects in mice
Precision CRISPR system averts hearing loss in mice - Boston Children's Discoveries
The kill-switch for CRISPR that could make gene-editing safer
Kill Switch for CRISPR Could Make Gene Editing Safer - Scientific American
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
A new research revealed that the CRISPR–Cas9 genome editing technique may increase cancer risk - Biotech Advisers
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine
Nature journal retracts controversial CRISPR paper after authors admit results may be wrong – Retraction Watch
CRISPR: gene editing is just the beginning : Nature News & Comment
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy | Nature Medicine
Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, Sato and colleagues (featured on p 256 of this month's issue) introduce various combinations of mutations associated with human intestinal tumors
New CRISPR genome-editing system can target disease-causing genetic variations – Harvard Gazette
PDF) The CRISPR tool kit for genome editing and beyond
First CRISPR editing trial results assuage safety concerns
CRISPR gene editing - Wikipedia
